Athanasiou Stavros, Grigoriadis Themos, Giannoulis George, Protopapas Athanasios, Antsaklis Aris
First Department of Obstetrics & Gynecology, Urogynecology Unit, University of Athens, 98A Vas. Sofias Avenue, 11528 Athens, Greece.
Int Urogynecol J. 2013 Mar;24(3):393-9. doi: 10.1007/s00192-012-1859-z. Epub 2012 Jul 10.
We assessed the efficacy of midurethral slings (MUS) in women with urodynamically proven mixed incontinence (UMI).
A prospective study was carried out in women with UMI in whom conservative treatment failed and who underwent MUS. Pre- and postoperative assessment included: completion of the validated ICIQ-FLUTS questionnaire, POP-Q examination and urodynamics (UDS). The primary outcome was the assessment of symptoms at 12 months. Secondary outcomes included assessment of postoperative UDS findings and evaluation of differences in symptoms and UDS diagnosis between the TVT and TVT-O groups.
Eighty-five women were included; 44 (49.2%) underwent TVT and 41 (51.8%) underwent TVT-O. Concomitant prolapse surgery was performed in 65 out of 85 patients (76.5%). At 12 months' follow-up there was a statistically significant reduction in stress urinary incontinence (p < 0.001), urge urinary incontinence (p < 0.001), urgency (p = 0.021) and frequency (p = 0.014). Depending on the symptom 10.6% to 24.7% of women reported deterioration of symptoms. UDS at 12 months revealed the absence of urodynamic stress incontinence (USI) in 82.4% of patients and no evidence of detrusor overactivity (DO) in 35.3%. No differences in symptoms were found between the TVT and TVT-O group, but the absence of DO was more common in the TVT group (48.5% vs 22.7%, p = 0.014).
Placement of MUS alleviates incontinence and overactive bladder symptoms in patients with UMI. TVT causes similar subjective improvement to TVT-O, but resulted in higher resolution of DO. Our study provides data that could be helpful in informing patients preoperatively of the potential impact that the MUS may have on each individual symptom separately, including the likelihood of symptom deterioration.
我们评估了中段尿道吊带术(MUS)对尿动力学证实为混合性尿失禁(UMI)女性患者的疗效。
对保守治疗失败且接受MUS的UMI女性患者进行了一项前瞻性研究。术前和术后评估包括:完成经过验证的ICIQ-FLUTS问卷、盆腔器官脱垂定量(POP-Q)检查和尿动力学检查(UDS)。主要结局是评估12个月时的症状。次要结局包括评估术后UDS结果以及评估经闭孔无张力尿道中段吊带术(TVT)组和经耻骨后无张力尿道中段吊带术(TVT-O)组之间症状和UDS诊断的差异。
纳入85名女性;44名(49.2%)接受了TVT,41名(51.8%)接受了TVT-O。85名患者中有65名(76.5%)同时进行了盆底脱垂手术。在12个月的随访中,压力性尿失禁(p < 0.001)、急迫性尿失禁(p < 0.001)、尿急(p = 0.021)和尿频(p = 0.014)在统计学上有显著降低。根据症状,10.6%至24.7%的女性报告症状恶化。12个月时的UDS显示,82.4%的患者无尿动力学压力性尿失禁(USI),35.3%的患者无逼尿肌过度活动(DO)证据。TVT组和TVT-O组在症状方面未发现差异,但TVT组无DO更为常见(48.5%对22.7%,p = 0.014)。
MUS植入可缓解UMI患者的尿失禁和膀胱过度活动症状。TVT与TVT-O导致类似的主观改善,但TVT对DO的缓解效果更好。我们的研究提供的数据有助于在术前告知患者MUS可能对每个单独症状产生的潜在影响,包括症状恶化的可能性。